These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 35592543)
1. Inflammation-Related Gene Signature for Predicting the Prognosis of Head and Neck Squamous Cell Carcinoma. Lu Y; Jia Z Int J Gen Med; 2022; 15():4793-4805. PubMed ID: 35592543 [TBL] [Abstract][Full Text] [Related]
2. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
3. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W J Oncol; 2022; 2022():5468858. PubMed ID: 36467500 [TBL] [Abstract][Full Text] [Related]
4. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma. Yang F; Zhou LQ; Yang HW; Wang YJ Front Genet; 2022; 13():927614. PubMed ID: 36092911 [No Abstract] [Full Text] [Related]
5. Immune-related gene signature for predicting the prognosis of head and neck squamous cell carcinoma. She Y; Kong X; Ge Y; Yin P; Liu Z; Chen J; Gao F; Fang S Cancer Cell Int; 2020; 20():22. PubMed ID: 31988638 [TBL] [Abstract][Full Text] [Related]
6. Development of an Immunogenomic Landscape-Based Prognostic Index of Head and Neck Squamous Cell Carcinoma. Long J; Zhang S; Zeng X; Ouyang Y; Wang Y; Hu Z; Ye Y; Wu W; Jin F; Zhou S; Zeng Z Front Mol Biosci; 2020; 7():586344. PubMed ID: 33330624 [TBL] [Abstract][Full Text] [Related]
7. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
8. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
9. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes. Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G Front Genet; 2022; 13():1085700. PubMed ID: 36579330 [No Abstract] [Full Text] [Related]
10. A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma. Zhou W; Feng M; Qi F; Qiao J; Fan L; Zhang L; Hu X; Huang C Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):953-963. PubMed ID: 38063904 [TBL] [Abstract][Full Text] [Related]
11. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a GRGPI model for predicting the prognostic and treatment outcomes in head and neck squamous cell carcinoma. Han F; Wang HZ; Chang MJ; Hu YT; Liang LZ; Li S; Liu F; He PF; Yang XT; Li F Front Oncol; 2022; 12():972215. PubMed ID: 36713509 [TBL] [Abstract][Full Text] [Related]
13. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
14. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma. Yang J; Xie K; Li C Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related]
16. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients. Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320 [TBL] [Abstract][Full Text] [Related]
17. Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma. Wang L; Zhang Y; Li H; Peng J; Gao C; Yu Q; Gao P; Li L; Chen K; Ye F Transl Cancer Res; 2024 Mar; 13(3):1367-1381. PubMed ID: 38617526 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Prognostic Signature Based on the Lysine Crotonylation Regulators in Head and Neck Squamous Cell Carcinoma. Jiang L; Yin X; Zhang H; Zhang X; Cao Z; Zhou M; Xu W Biomed Res Int; 2023; 2023():4444869. PubMed ID: 36814797 [TBL] [Abstract][Full Text] [Related]
19. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
20. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Qi X; Qi C; Qin B; Kang X; Hu Y; Han W Front Oncol; 2020; 10():541330. PubMed ID: 33072571 [No Abstract] [Full Text] [Related] [Next] [New Search]